Alaunos Therapeutics, Inc. (TCRT) › Total AssetsAlaunos Therapeutics, Inc. (TCRT) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $61.52M2011: $108.11M2012: $83.40M2013: $71.75M2014: $45.24M2015: $153.72M2016: $106.35M2017: $105.61M2018: $95.05M2019: $109.11M2020: $146.34M2021: $94.86M2022: $64.94M2023: $8.26M2024: $2.75M2025: $2.97M$2.97M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$2.97M+7.7%2024$2.75M-66.7%2023$8.26M-87.3%2022$64.94M-31.5%2021$94.86M-35.2%2020$146.34M+34.1%2019$109.11M+14.8%2018$95.05M-10.0%2017$105.61M-0.7%2016$106.35M-30.8%2015$153.72M+239.8%2014$45.24M-37.0%2013$71.75M-14.0%2012$83.40M-22.9%2011$108.11M+75.7%2010$61.52M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share